600568.SS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 08:49):

Zhongzhu Healthcare Holding Co.,Ltd constructs and develops real estate properties in China. It also produces ophthalmic drugs; researches and develops natural botanical drugs...

Stats
Dagens volum	6.74M
Gjennomsnittsvolum	6.55M
Markedsverdi	2.91B
EPS	CNY-0.108 ( 2023-06-30 )
Neste inntjeningsdato	( CNY0 ) 2024-05-08
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-8.59
ATR14	CNY0.00400 (0.27%)

Volum Korrelasjon

Lang: -0.10 (neutral)

Kort: -0.96 (very strong negative)

Signal:(50.617) Neutral

Zhongzhu Healthcare Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Zhongzhu Healthcare Korrelasjon - Valuta/Råvare

0.40
( neutral )

0.43
( neutral )

0.00
( neutral )

-0.23
( neutral )

Zhongzhu Healthcare Økonomi

Annual	2023
Omsetning:	CNY580.06M
Bruttogevinst:	CNY51.08M (8.81 %)
EPS:	CNY-0.170

FY	2023
Omsetning:	CNY580.06M
Bruttogevinst:	CNY51.08M (8.81 %)
EPS:	CNY-0.170

FY	2022
Omsetning:	CNY505.97M
Bruttogevinst:	CNY127.46M (25.19 %)
EPS:	CNY-0.400

FY	2021
Omsetning:	CNY581.06M
Bruttogevinst:	CNY166.24M (28.61 %)
EPS:	CNY-0.105

Financial Reports:

No articles found.

Zhongzhu Healthcare

Zhongzhu Healthcare Holding Co.,Ltd constructs and develops real estate properties in China. It also produces ophthalmic drugs; researches and develops natural botanical drugs. In addition, it researches and develops drugs, such as recombinant human endostatin adenovirus injection, which is an anticancer gene therapy; Genistein capsule for the treatment of postmenopausal osteoporosis; and motherwort that is primarily a gynecological drug. Further, the company offers medical instruments, including radiation therapy, hyperthermia, phototherapy, and ultrasound diagnosis, as well as develops imaging breast tumor detection systems. Additionally, it offers medical services. The company was formerly known as Zhongzhu Holding Co., Ltd. and changed its name to Zhongzhu Healthcare Holding Co.,Ltd in June 2016. Zhongzhu Healthcare Holding Co.,Ltd was founded in 1970 and is headquartered in Qianjiang, China.